| Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses M Letko, A Marzi, V Munster Nature microbiology 5 (4), 562-569, 2020 | 3533 | 2020 |
| DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus A Marzi, T Gramberg, G Simmons, P Möller, AJ Rennekamp, ... Journal of virology 78 (21), 12090-12095, 2004 | 471 | 2004 |
| Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor H Hofmann, M Geier, A Marzi, M Krumbiegel, M Peipp, GH Fey, ... Biochemical and biophysical research communications 319 (4), 1216-1221, 2004 | 332 | 2004 |
| DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets C Chaipan, EJ Soilleux, P Simpson, H Hofmann, T Gramberg, A Marzi, ... Journal of virology 80 (18), 8951-8960, 2006 | 317 | 2006 |
| Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis P Aleksandrowicz, A Marzi, N Biedenkopf, N Beimforde, S Becker, ... The Journal of infectious diseases 204 (suppl_3), S957-S967, 2011 | 311 | 2011 |
| Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates A Marzi, F Engelmann, F Feldmann, K Haberthur, WL Shupert, D Brining, ... Proceedings of the National Academy of Sciences 110 (5), 1893-1898, 2013 | 310 | 2013 |
| K18-hACE2 mice develop respiratory disease resembling severe COVID-19 CK Yinda, JR Port, T Bushmaker, I Offei Owusu, JN Purushotham, ... PLoS pathogens 17 (1), e1009195, 2021 | 278 | 2021 |
| Proteolytic activation of the 1918 influenza virus hemagglutinin C Chaipan, D Kobasa, S Bertram, I Glowacka, I Steffen, ... Journal of virology 83 (7), 3200-3211, 2009 | 277 | 2009 |
| VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain A Marzi, SJ Robertson, E Haddock, F Feldmann, PW Hanley, DP Scott, ... Science 349 (6249), 739-742, 2015 | 250 | 2015 |
| S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients H Hofmann, K Hattermann, A Marzi, T Gramberg, M Geier, M Krumbiegel, ... Journal of virology 78 (12), 6134-6142, 2004 | 250 | 2004 |
| LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus T Gramberg, H Hofmann, P Möller, PF Lalor, A Marzi, M Geier, ... Virology 340 (2), 224-236, 2005 | 248 | 2005 |
| Nanopore sequencing as a rapidly deployable Ebola outbreak tool T Hoenen, A Groseth, K Rosenke, RJ Fischer, A Hoenen, SD Judson, ... Emerging infectious diseases 22 (2), 331, 2016 | 241 | 2016 |
| Ebola virus vaccines: an overview of current approaches A Marzi, H Feldmann Expert review of vaccines 13 (4), 521-531, 2014 | 214 | 2014 |
| Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina M Marschall, A Marzi, P aus dem Siepen, R Jochmann, M Kalmer, ... Journal of Biological Chemistry 280 (39), 33357-33367, 2005 | 187 | 2005 |
| Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever A Marzi, R Yoshida, H Miyamoto, M Ishijima, Y Suzuki, M Higuchi, ... PloS one 7 (4), e36192, 2012 | 160 | 2012 |
| Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine JE Blaney, A Marzi, M Willet, AB Papaneri, C Wirblich, F Feldmann, ... PLoS pathogens 9 (5), e1003389, 2013 | 153 | 2013 |
| Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors H Hofmann, G Simmons, AJ Rennekamp, C Chaipan, T Gramberg, ... Journal of virology 80 (17), 8639-8652, 2006 | 147 | 2006 |
| Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies E Nakayama, A Yokoyama, H Miyamoto, M Igarashi, N Kishida, ... Clinical and vaccine immunology 17 (11), 1723-1728, 2010 | 141 | 2010 |
| The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials E Suder, W Furuyama, H Feldmann, A Marzi, E de Wit Human vaccines & immunotherapeutics 14 (9), 2107-2113, 2018 | 140 | 2018 |
| A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment B Rockx, KN Bossart, F Feldmann, JB Geisbert, AC Hickey, D Brining, ... Journal of virology 84 (19), 9831-9839, 2010 | 139 | 2010 |